Distribution of molecular subtypes of advanced lung adenocarcinoma and clinical outcomes in a center of Argentina

Recondo Jr, Gonzalo; Denninghoff, Valeria; Cuello, María T; Lorente, Constanza; Greco, Martín; De La Vega, Máximo; Recondo, Gonzalo.
Medicina (B.Aires) ; 78(6): 385-394, Dec. 2018. ilus, graf, tab
Artículo en Inglés | LILACS | ID: biblio-976135

Documentos relacionados

  1. Distribution of molecular subtypes of advanced lung adenocarcinoma and clinical outcomes in a center of Argentina.
  2. Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.
  3. Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer.
  4. Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression.
  5. [The clinical and pathological features, biomarker characteristics and prognosis analysis of lung adenosquamous carcinoma].
  6. An Observational Study Evaluating the Performance of LENT Score in the Selected Population of Malignant Pleural Effusion from Lung Adenocarcinoma in Singapore.
  7. Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma.
  8. Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib.
  9. Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.
  10. Clinicopathological, molecular features and prognosis of colorectal cancer with mucinous component.